en Iodamide

Iodamide
Clinical data
Trade names	Renovue
AHFS/Drugs.com	International Drug Names
ATC code	V08AA03 (WHO) ;
Identifiers
	IUPAC name 3-Acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid;
CAS Number	440-58-4 ;
PubChem CID	3723;
DrugBank	DB08948 ;
ChemSpider	3592 ;
UNII	4RII332O0R;
KEGG	D01376 ;
ChEMBL	ChEMBL1201239 ;
CompTox Dashboard (EPA)	DTXSID1023150 ;
ECHA InfoCard	100.006.479
Chemical and physical data
Formula	C12H11I3N2O4
Molar mass	627.943 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)NCC1=C(C(=C(C(=C1I)NC(=O)C)I)C(=O)O)I;
	InChI InChI=1S/C12H11I3N2O4/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21) ; Key:VVDGWALACJEJKG-UHFFFAOYSA-N ;
	(what is this?) (verify)

Iodamide (trade name Renovue) is a pharmaceutical drug used as an iodinated contrast medium for X-ray imaging. Its uses include imaging of the uterus and fallopian tubes.^[1]^[2]

References

^ Rosenfield AT, Putman CE, Ulreich S, Koss N (1977). "Double-blind comparison of iodamide and diatrizoate for excretory urography". The Yale Journal of Biology and Medicine. 50 (6): 631–6. PMC 2595582. PMID 345632.
^ Mohd Nor H, Jayapragasam K, Abdullah B (July 2009). "Diagnostic image quality of hysterosalpingography: ionic versus non ionic water soluble iodinated contrast media". Biomedical Imaging and Intervention Journal. 5 (3): e29. doi:10.2349/biij.5.3.e29. PMC 3097785. PMID 21611058.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] Rosenfield AT, Putman CE, Ulreich S, Koss N (1977). "Double-blind comparison of iodamide and diatrizoate for excretory urography". The Yale Journal of Biology and Medicine. 50 (6): 631–6. PMC 2595582. PMID 345632.

[2] Mohd Nor H, Jayapragasam K, Abdullah B (July 2009). "Diagnostic image quality of hysterosalpingography: ionic versus non ionic water soluble iodinated contrast media". Biomedical Imaging and Intervention Journal. 5 (3): e29. doi:10.2349/biij.5.3.e29. PMC 3097785. PMID 21611058.

[1]

[2]